TIROMU

In terms of product development, TIROMU has also achieved key breakthroughs. Its self-developed retinal injection surgical robot has entered the clinical trial stage and is expected to complete the trials this year and initiate the registration process. Meanwhile, the 2.0 version of the product has also been fully developed. By integrating intraoperative OCT imaging, it enables real-time automatic surgical path planning and navigation, potentially becoming the first ophthalmic surgical robot in the industry with "autonomous driving" capabilities, further enhancing the standardization and intelligence of ophthalmic microsurgery.